Cobionix, a Canada-based medical robotics company, recently closed a $3 million funding round. TitletownTech, a venture capital firm backed by Microsoft and the Green Bay Packers, led the investment. Lions Investment and Dr. Paul McBeth, a medical robotics expert and investor, also participated.
The company develops Codi, an autonomous medical robotics platform. This platform delivers diagnostic ultrasound procedures using artificial intelligence-driven autonomy to remote locations. Furthermore, Codi is highly configurable, supporting numerous different applications.
Initially, Codi will focus on ultrasound capabilities. Unlike traditional robotics systems, Codi adapts rapidly for various clinical applications through simple tool changes. Its software updates remotely, enhancing its versatility.
Advancing Remote Diagnostic Capabilities
Ultrasound is a widely used diagnostic imaging technique. It employs high-frequency sound waves to create internal body images. This painless procedure assists with evaluating organs, identifying tumors, and assessing injuries. Consequently, it often helps prepare for or avoid more invasive options.
A robot assisting a remote technician can alleviate the need for on-site personnel. This also means patients avoid travel, reducing strain and wait times. Companies like GE HealthCare also develop advanced medical imaging solutions, highlighting the market's demand for innovative diagnostic tools.
Founded in 2021, Cobionix first demonstrated an autonomous robot for intramuscular vaccine injections. The company expanded its team to build the Codi platform, designed to augment remote diagnostic technicians.
The new funding will support pilot programs for Codi starting this August. Moreover, it will help scale the commercial launch in the United States during 2026. Cobionix currently conducts research and pilot projects across the U.S., Canada, and the United Kingdom, similar to how Intuitive Surgical has expanded its robotic surgery systems globally.
